An approved design file is not yet a released production label.
Use this gummy supplement label and artwork approval checklist to reconcile formula, required U.S. label statements, claims, print proof, controlled versions and first-batch evidence before commercial release.
Release one identified version for one identified product and market
A useful approval record answers six questions: which product and formula the label describes, which market rules apply, what claims and evidence were reviewed, which exact artwork revision was approved, which printer proof matches it, and how production prevents a different version from reaching the line.
The six-stage label and artwork evidence chain
Scope
Product, SKU, formula, market, package, count and responsible parties.
Content
Required statements, serving, ingredients, allergens, directions and warnings.
Claims
Classification, substantiation, exact wording, disclaimer and notification path.
Proof
Dieline, dimensions, barcode, print zones, readability and lot/date area.
Approve
Named reviewers, comments closed, revision, date and effective status.
Release
Line copy, reconciliation, first-batch checks, discrepancy and disposition.
Do not treat these three files as the same approval
1. Marketing concept
Shows hierarchy, brand direction and proposed copy. It can be useful for discussion but may still contain placeholder facts, unreviewed claims or an outdated formula.
2. Regulatory/quality-approved artwork
Contains the reviewed content for the identified product, market and package. It carries a controlled file name or revision, approval record and effective status.
3. Printer or production proof
Shows how the approved artwork maps to the actual substrate, size, color separations and production setup. Differences from the approved artwork require review—not silent acceptance.
Twelve checks before approving a U.S. gummy supplement label
1. Lock the approval scope
- Brand, product name, SKU and target market
- Approved formula and specification revisions
- Gummy count, serving, package and net contents
- Label owner, manufacturer/packer/distributor roles and approvers
2. Confirm the statement of identity
- Product is identified as a dietary supplement using applicable wording
- Identity is not confused with a flavor, benefit or brand name
- Wording matches the product and intended market
- Principal-display-panel review is documented
3. Verify net quantity and count
- Declared contents match the commercial package
- Count, weight or other declaration uses the applicable basis
- Location and prominence are reviewed on the actual panel
- Artwork agrees with fill and packaging specifications
4. Reconcile Supplement Facts
- Serving size and servings per container match directions and count
- Each declared dietary ingredient matches the approved formula
- Ingredient form, amount, unit and Daily Value treatment are reviewed
- Footnotes and other panel content use the applicable format
5. Reconcile other ingredients
- Gelling system, sweeteners, flavors, colors, acids, oils and coatings are included as applicable
- Names and order are checked against the actual formula
- Ingredients already declared in Supplement Facts are handled correctly
- Supplier or formula substitutions trigger a label-impact review
6. Complete the allergen review
- Review the complete formula and processing inputs—not only the front label
- Assess applicable major-food-allergen disclosure, including sesame
- Separate ingredient facts from facility or cross-contact statements
- Reopen the review when a supplier, ingredient or process changes
7. Confirm the responsible-firm details
- Name and place of business are accurate for the stated role
- “Manufactured for,” “distributed by” or other qualifier is reviewed where applicable
- Domestic address or phone pathway for serious adverse-event reports is present as required
- Contact information is operational and matches controlled company records
8. Review directions, warnings and storage
- Directions agree with serving size and intended population
- Formula- and population-specific cautions are assessed
- Storage wording agrees with the evidence and package assumptions
- No universal warning or shelf-life phrase is copied without review
9. Classify and substantiate every claim
- Identify nutrient-content, structure/function, health, disease or other wording
- Retain support for the exact claim and product context
- Keep implied messages, graphics and testimonials in scope
- Remove disease-treatment or prevention wording that is not lawful for the product
10. Control the disclaimer and notification path
- For structure/function wording, review the applicable disclaimer and placement
- Confirm the responsible party and notification timing/process
- Link any symbol clearly to the claim it qualifies
- Do not use a disclaimer to rescue an otherwise misleading claim
11. Inspect the technical artwork
- Approved dieline, trim, bleed, safe area and label dimensions
- Readable type, contrast and panel placement on the actual package
- Barcode, quiet zone and scannability where used
- Reserved lot/date area, printer marks, substrate, adhesive and color proof
12. Release and control the revision
- Unique file name, artwork number, revision and effective date
- Named brand, regulatory, quality, packaging and manufacturing approvals
- Obsolete electronic and physical copies blocked from use
- Master/batch record references, label reconciliation and first-batch checks
Approval matrix: separate four layers of review
| Layer | Core question | Evidence to match | Typical decision owner |
|---|---|---|---|
| Required/regulated content | Does the label contain the applicable identity, quantity, nutrition, ingredients and responsible-firm information? | Formula, serving, package, market review and controlled copy | Brand regulatory/legal, with quality and manufacturer input |
| Conditional content | Do formula, population, claims or presentation trigger additional wording or obligations? | Allergen assessment, warnings, claim support, disclaimer and notification record | Brand regulatory/legal and responsible firm |
| Brand content | Are voluntary statements truthful, nonmisleading and consistent with the approved evidence? | Claim file, substantiation, testing scope, certifications and publication rights | Brand marketing plus regulatory/legal approval |
| Production controls | Can the correct approved revision be printed, received, issued, reconciled and traced? | Printer proof, artwork revision, packaging specification, master/batch references and first-batch record | Packaging, manufacturing quality and operations |
What current FDA labeling guidance and 21 CFR Part 111 connect
FDA's dietary supplement labeling guide identifies five basic statements for a dietary supplement label: a statement of identity, net quantity of contents, nutrition labeling, an ingredient list, and the name and place of business of the manufacturer, packer or distributor. That list is a starting point—not a substitute for the detailed requirements in 21 CFR Part 101 or a product-specific review.
- Identity and ingredients: 21 CFR 101.3 addresses the statement of identity. Section 101.4 addresses ingredient designation and order, while dietary-supplement nutrition labeling is addressed in section 101.36.
- Responsible firm: 21 CFR 101.5 addresses the name and place of business. FDA's current dietary-supplement Q&A also notes the domestic address or phone requirement for serious adverse-event reports.
- Claims: FDA's labeling guide separates claim categories. Structure/function and related statements must be truthful and not misleading and can carry disclaimer and postmarketing-notification obligations. A disclaimer does not authorize a disease claim.
- Packaging and label controls: 21 CFR 111.70 includes label and packaging specifications. Sections 111.160, 111.210, 111.260 and 111.410 connect received labels, representative label or cross-references, batch identifiers, examinations, reconciliation and traceability.
The practical result is a two-way reconciliation: regulated and voluntary copy must match the approved product basis, while the production label must match the approved artwork basis. A correct sentence in the wrong revision is still a release failure.
Who signs what?
Brand / responsible firm
Owns market intent, product positioning, contact details, claim decisions, final label authorization and applicable reporting or notification duties.
Regulatory / legal
Reviews applicable label rules, claims, substantiation, disclaimers, warnings and exact wording for the intended U.S. market.
Manufacturer / quality
Reconciles the approved formula, specification, package and production controls; manages effective versions, label receipt/use and batch evidence within agreed responsibilities.
Designer / printer / packaging
Translates controlled content into the correct dieline and production proof and routes every content or technical difference back for approval.
First-production-batch label release checks
- Match identifiers. Confirm the product, formula, batch, package, artwork and printer-proof revisions against the effective controlled records.
- Examine before operation. Verify the packaging and label setup against the applicable master-manufacturing-record requirements and line instructions.
- Inspect the packaged presentation. Check the correct label, placement, legibility, count/net-contents context, lot/date coding and defined barcode behavior.
- Reconcile and segregate. Account for issued, used, returned or destroyed labels under the applicable procedure and prevent obsolete versions from re-entry.
- Record discrepancies. Do not replace investigation, material review or quality disposition with an informal artwork correction.
- Close with traceability. Retain the effective revision and applicable approval, examination and disposition records so the distributed lot can be reconstructed.
Copy-ready gummy label release request
Send a scoped request before asking a manufacturer or reviewer to “check the label.” Remove confidential information that is not needed for the review.
Related evidence tools
Use the product specification checklist to lock the formula and acceptance basis, the packaging change-control checklist when a label, printer, bottle or pack-out changes, the sample-to-commercial transfer checklist to match the first batch, and the project evidence register to control document status, disclosure rights and exact public wording. The probiotic page separates strain and CFU time point; the mushroom page separates species, source and marker wording; the omega-3 page separates source oil, EPA/DHA amount and oxidation evidence; and the inositol page keeps each isomer amount, serving, ratio calculation and label basis traceable.
Official references
- FDA: Dietary Supplement Labeling Guide
- FDA: General Dietary Supplement Labeling
- FDA: Dietary Supplement Label Claims
- FDA: Structure/Function and Related Claim Notifications
- FDA: Questions and Answers on Dietary Supplements
- Electronic Code of Federal Regulations: 21 CFR Part 101
- Electronic Code of Federal Regulations: 21 CFR Part 111
Label and artwork FAQ
Is a designer-approved gummy label ready for production?
Not by design approval alone. The released artwork should be matched to the correct product, formula, market and package; reviewed for applicable label content and claims; checked against the printer proof; assigned a controlled revision; and connected to production and quality records.
What are the five basic label statements FDA identifies for dietary supplements?
FDA's dietary supplement labeling guide identifies a statement of identity, net quantity of contents, nutrition labeling, an ingredient list, and the name and place of business of the manufacturer, packer or distributor. The exact content, placement, exemptions and formatting require a product-specific review.
Can a gummy manufacturer approve a brand's U.S. claims?
Responsibilities should be defined in writing. A manufacturer can flag formula, production or artwork inconsistencies, but the responsible brand and its qualified regulatory or legal reviewers should determine claim classification, substantiation, required disclaimer or notification, and final market wording.
Does a Supplement Facts panel replace a formula-to-label reconciliation?
No. The panel, other-ingredients list, allergen review, serving instructions and claims must be reconciled to the approved formula and intended market. A visually correct panel can still contain the wrong ingredient form, amount, serving basis or revision.
What should be checked on the first production batch after label approval?
Verify the product and batch against the effective label revision, inspect label and packaging presentation against established specifications, confirm lot and date coding and barcode behavior where applicable, reconcile label use, document discrepancies, and retain the applicable quality-control disposition.
Need to reconcile a formula, package and label revision?
Share the identified project scope and unresolved questions. Our U.S. team can organize a project-specific review request for the responsible parties.
Request a Project Review